The PennZone

PITTSBURGH, Aug. 6, 2024 ~ Journalist: MolecuLight Corp., a leading company in fluorescence imaging technology for detecting harmful bacteria in wound care, has recently announced the publication of a peer-reviewed clinical research study showcasing the transformative capabilities of their technology. The study, conducted on 167 Medicare beneficiaries across 55 Long Term Care (LTC) and Skilled Nursing Facilities (SNF) in the US, highlights the significant improvements in pressure injury outcomes and infection control achieved with the use of MolecuLight.

The article, titled "Improving Wound Healing and Infection Control in Long-term Care with Bacterial Fluorescence Imaging," was published by Martha R. Kelso and her colleagues in the latest edition of Advances in Skin & Wound Care journal. The researchers reported impressive results, showing a remarkable improvement in pressure injury outcomes among patients with complex healing challenges. This serves as a testament to the effectiveness of MolecuLight technology, even in the most challenging patient cases.

More on The PennZone

• UK Financial Ltd Executes 100% Success Rate on All ERC-3643 Transfers to Coin Holders of MayaCat Regulated Security Token and Maya Preferred PRA
• Blank Space: The Unofficial Taylor Swift Tribute Brings Eras Tour Magic To Cities Across America
• Love Must Be the Guide: Live Good Shares a Message of Humanity, Compassion and Hope
• D.R. Crotzer Announces A New Science Fiction Book Series Exploring Life Energy, Dreams, and the Mystery of Existence
• Vinnie Rocco Opens AgentiX Minds To Help Business Owners & Execs Learn AI Agents

The study compared outcomes between patients who received standard care alone and those who had MolecuLight real-time fluorescence integrated into their treatment plan. The results showed that patients who were imaged with MolecuLight saw a 71% increase in wound healing by 12 weeks, healed 28% faster, and were 1.8 times more likely to heal their wound within this time frame. Additionally, there was a significant decrease (75%) in severe infection complications such as cellulitis, osteomyelitis, gangrene, sepsis, and wound-related hospitalization when MolecuLight was used to guide patient care.

Lead author Martha R. Kelso expressed her excitement about these findings stating, "We are very excited to share with the world through concrete findings what we have been experiencing firsthand with our LTC/SNF patients." She further added that "the positive effects that the MolecuLight technology has on all patients, even those who are severely sick and compromised, is outstanding. Increasing healing rates, shortening healing times, and avoiding complications is how you make a difference. All patients deserve the best!"

More on The PennZone

• Color Card Administrator Highlights Growing Enterprise Demand for Operational Infrastructure in Business Card Identity Governance
• American Properties Celebrates Grand Opening and Ribbon Cutting Ceremony at Heritage at South
• MoMojo Records signs Arlen Roth; "Blues Grass" slated for August 7, 2026 release
• Crosswalk Ministries USA Announces 2026 Child and Family Well-Being Conference in Stockbridge, Georgia
• Autism Podcast Helps Parents Understand Why Behavior Is Communication, Not Defiance

Anil Amlani, CEO of MolecuLight, also shared his enthusiasm for these groundbreaking results. "We are thrilled to see such compelling evidence of the impact our technology can have on patient outcomes, particularly in such a vulnerable and systematically neglected patient population." He emphasized that "the significant improvements in wound healing and the dramatic reduction in infection complications underscore the potential of MolecuLight to revolutionize wound care, in any place of service and against the most challenging of clinical backgrounds."

This research serves as another example of MolecuLight's commitment to improving patient care and advancing the field of wound management. With these remarkable outcomes now published in a peer-reviewed journal, it is hoped that more healthcare professionals will adopt this technology to provide better care for their patients.

---

Show All News | Disclaimer | Report Violation